In an article published on November 18, 2015 the non-profit organization Health and Environment Alliance (HEAL) informs that a court hearing of Sweden’s case against the European Commission (EC) took place at the European Court of Justice in Luxembourg on November 17, 2015. In July 2014, Sweden sued the EC for missing the legal deadline to deliver criteria for the identification of endocrine disrupting chemicals (EDCs) by the end of 2013 (FPF reported). Sweden’s case is supported by the EU Council of governments, the European Parliament, and EU Member States (MS) Denmark, France and the Netherlands. The delay in setting criteria to identify EDCs is “keeping Europeans exposed to chemicals that contribute to breast and prostate cancer, diabetes and obesity, infertility and learning disorders,” stated Lisette van Vliet of HEAL. Currently, the EC is undertaking an impact assessment on four different options for setting criteria to identify EDCs (FPF reported). This procedure is possibly further delaying the decision on EU-wide EDC criteria until 2017, HEAL writes.
Read more
HEAL (November 18, 2015). “EU court hearing puts spotlight on Commission delay over hormone disrupting chemicals.”
ChemSec (November 18, 2015). “EU court hearing on Commission delay regarding EDC criteria.”
